Protalix

Recombinant Therapeutics Proteins Using Plant Cell-Based Expression System.

Launch date

1994

Employees

Market cap

Net debt

-

Enterprise valuation

$65m (Public information from May 2024)

Karmiel North District (HQ)

http://www.protalix.com

https://www.linkedin.com/company/protalix-biotherapiutics

View job openings